New vaccine aims to train the immune system to fight deadly brain cancer

NCT ID NCT06622434

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 29 times

Summary

This study tests a new vaccine designed to help the immune system recognize and attack glioblastoma, an aggressive brain cancer. About 35 adults who have already had surgery and standard chemoradiation will receive the vaccine. The goal is to see if it is safe and whether it triggers a strong immune response against the tumor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEWLY DIAGNOSED GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurology, Hopital Saint louis (APHP)

    RECRUITING

    Paris, 75010, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Neurology, Hopital de la Salpêtrière

    RECRUITING

    Paris, Idf, 75013, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Neurology, University Hospital of Besançon

    NOT_YET_RECRUITING

    Besançon, Bourgogne-Franche-Comté, 25030, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical Oncology Department, Eugène Marquis Centre

    NOT_YET_RECRUITING

    Rennes, Brittany Region, 35000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Neuro-oncology Department, La Timone Hospital

    NOT_YET_RECRUITING

    Marseille, Provence-Alpes-Côte d'Azur Region, 13005, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.